|A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1|
Y Miki, J Swensen, D Shattuck-Eidens, PA Futreal, K Harshman, ...
Science 266 (5182), 66-71, 1994
|Triple-negative breast cancer: clinical features and patterns of recurrence|
R Dent, M Trudeau, KI Pritchard, WM Hanna, HK Kahn, CA Sawka, ...
Clinical cancer research 13 (15), 4429-4434, 2007
|Identification of the breast cancer susceptibility gene BRCA2|
R Wooster, G Bignell, J Lancaster, S Swift, S Seal, J Mangion, N Collins, ...
Nature 378 (6559), 789-792, 1995
|Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies|
A Antoniou, PDP Pharoah, S Narod, HA Risch, JE Eyfjord, JL Hopper, ...
The American Journal of Human Genetics 72 (5), 1117-1130, 2003
|Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families|
D Ford, DF Easton, M Stratton, S Narod, D Goldgar, P Devilee, DT Bishop, ...
The American Journal of Human Genetics 62 (3), 676-689, 1998
|Localization of a Breast Cancer Susceptibility Gene, BRCA2, to Chromosome 13q12-13|
R Wooster, SL Neuhausen, J Mangion, Y Quirk, D Ford, N Collins, ...
Science 265 (5181), 2088-2090, 1994
|Risks of cancer in BRCA1-mutation carriers|
D Ford, DF Easton, DT Bishop, SA Narod, DE Goldgar
The Lancet 343 (8899), 692-695, 1994
|Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations|
TR Rebbeck, HT Lynch, SL Neuhausen, SA Narod, L Van't Veer, ...
New England Journal of Medicine 346 (21), 1616-1622, 2002
|Bilateral Prophylactic Mastectomy Reduces Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group|
TR Rebbeck, T Friebel, HT Lynch, SL Neuhausen, L Van’t Veer, ...
Journal of clinical oncology 22 (6), 1055-1062, 2004
|Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination|
E Warner, DB Plewes, KA Hill, PA Causer, JT Zubovits, RA Jong, ...
Jama 292 (11), 1317-1325, 2004
|A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25|
RJ Hung, JD McKay, V Gaborieau, P Boffetta, M Hashibe, D Zaridze, ...
Nature 452 (7187), 633-637, 2008
|Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations.|
H Meijers-Heijboer, A Van den Ouweland, J Klijn, M Wasielewski, ...
Nature genetics 31 (1), 2002
|BRCA1 and BRCA2: 1994 and beyond|
SA Narod, WD Foulkes
Nature Reviews Cancer 4 (9), 665-676, 2004
|Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer|
HA Risch, JR McLaughlin, DEC Cole, B Rosen, L Bradley, E Kwan, ...
The American Journal of Human Genetics 68 (3), 700-710, 2001
|BRCA1 testing in families with hereditary breast-ovarian cancer: a prospective study of patient decision making and outcomes|
C Lerman, S Narod, K Schulman, C Hughes, A Gomez-Caminero, ...
Jama 275 (24), 1885-1892, 1996
|Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer|
DD Bowtell, S BŲhm, AA Ahmed, PJ Aspuria, RC Bast Jr, V Beral, ...
Nature reviews Cancer 15 (11), 668-679, 2015
|Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial|
AB Miller, C Wall, CJ Baines, P Sun, T To, SA Narod
Bmj 348, 2014
|Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin–cohort study in Ontario, Canada|
HA Risch, JR McLaughlin, DEC Cole, B Rosen, L Bradley, I Fan, J Tang, ...
Journal of the National Cancer Institute 98 (23), 1694-1706, 2006
|Oral contraceptives and the risk of hereditary ovarian cancer|
SA Narod, H Risch, R Moslehi, A DÝrum, S Neuhausen, H Olsson, ...
New England Journal of Medicine 339 (7), 424-428, 1998
|Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers|
TR Rebbeck, AM Levin, A Eisen, C Snyder, P Watson, L Cannon-Albright, ...
Journal of the National Cancer Institute 91 (17), 1475-1479, 1999